Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Comput Econ ; 60(1): 47-69, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34230769

RESUMEN

This work presents a novel application of the Stochastic Dual Dynamic Problem (SDDP) to large-scale asset allocation. We construct a model that delivers allocation policies based on how the portfolio performs with respect to user-defined (synthetic) indexes, and implement it in a SDDP open-source package. Based on US economic cycles and ETF data, we generate Markovian regime-dependent returns to solve an instance of multiple assets and 28 time periods. Results show our solution outperforms its benchmark, in both profitability and tracking error.

2.
Neurol Res ; 39(7): 649-659, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28398193

RESUMEN

OBJECTIVE: Scopolamine (SCO) administration to rats induces molecular features of AD and other dementias, including impaired cognition, increased oxidative stress, and imbalanced cholinergic transmission. Although mitochondrial dysfunction is involved in different types of dementias, its role in cognitive impairment induced by SCO has not been well elucidated. The aim of this work was to evaluate the in vivo effect of SCO on different brain mitochondrial parameters in rats to explore its neurotoxic mechanisms of action. METHODS: Saline (Control) or SCO (1 mg/kg) was administered intraperitoneally 30 min prior to neurobehavioral and biochemical evaluations. Novel object recognition and Y-maze paradigms were used to evaluate the impact on memory, while redox profiles in different brain regions and the acetylcholinesterase (AChE) activity of the whole brain were assessed to elucidate the amnesic mechanism of SCO. Finally, the effects of SCO on brain mitochondria were evaluated both ex vivo and in vitro, the latter to determine whether SCO could directly interfere with mitochondrial function. RESULTS: SCO administration induced memory deficit, increased oxidative stress, and increased AChE activities in the hippocampus and prefrontal cortex. Isolated brain mitochondria from rats administered with SCO were more vulnerable to mitochondrial swelling, membrane potential dissipation, H2O2 generation and calcium efflux, all likely resulting from oxidative damage. The in vitro mitochondrial assays suggest that SCO did not affect the organelle function directly. CONCLUSION: In conclusion, the present results indicate that SCO induced cognitive dysfunction and oxidative stress may involve brain mitochondrial impairment, an important target for new neuroprotective compounds against AD and other dementias.


Asunto(s)
Trastornos de la Memoria/metabolismo , Mitocondrias/metabolismo , Acetilcolinesterasa/metabolismo , Animales , Encéfalo/metabolismo , Calcio/metabolismo , Cationes Bivalentes/metabolismo , Modelos Animales de Enfermedad , Peróxido de Hidrógeno/metabolismo , Masculino , Aprendizaje por Laberinto/fisiología , Potencial de la Membrana Mitocondrial/fisiología , Dilatación Mitocondrial/fisiología , Estrés Oxidativo/fisiología , Distribución Aleatoria , Ratas Wistar , Reconocimiento en Psicología/fisiología , Escopolamina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA